Project Grant HT94252510876
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $538K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- This $448,133 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Michigan to investigate targeting the mycobiome (fungal microbiome) metabolism to reprogram the immunosuppressive pancreatic tumor microenvironment. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The...
- This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
- The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
- This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....
- The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
- The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
- This $624,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The grant supports advanced biomedical research focused on the role of epithelial AIM2 in Helicobacter pylori-associated gastric preneoplasia. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative medical solutions to address...
- The University of Michigan will receive $304,472 over two years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into regulating prostate skeletal bone metastases through TIM-3-dependent efferocytosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
- This $780,000 Project Grant was awarded on August 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The grant will support a 3-year research project titled "Lead Exposure and Sex-Specific Programming of Cardiovascular Disease Across the Life Course" focused on advancing biomedical research to transform healthcare for military service members, veterans, and the public. The...